Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.67 Million CAD | 17.21% |
| 2022 | 6.54 Million CAD | 1236.53% |
| 2021 | 490 Thousand CAD | -15.81% |
| 2020 | 582 Thousand CAD | -12.74% |
| 2019 | 667 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 2.17 Million CAD | 8.17% |
| 2007 | 2 Million CAD | 8.95% |
| 2006 | 1.84 Million CAD | -76.19% |
| 2005 | 7.74 Million CAD | 15.53% |
| 2004 | 6.7 Million CAD | 12.34% |
| 2003 | 5.96 Million CAD | 11.5% |
| 2002 | 5.35 Million CAD | 61.73% |
| 2001 | 3.3 Million CAD | 10.27% |
| 2000 | 3 Million CAD | 150.0% |
| 1999 | 1.2 Million CAD | 1100.0% |
| 1998 | 100 Thousand CAD | -75.0% |
| 1997 | 400 Thousand CAD | -20.0% |
| 1996 | 500 Thousand CAD | 400.0% |
| 1995 | 100 Thousand CAD | 0.0% |
| 1994 | 100 Thousand CAD | 0.0% |
| 1993 | 100 Thousand CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 8.39 Million CAD | 9.34% |
| 2024 Q2 | 12.15 Million CAD | 44.85% |
| 2023 Q3 | 12.16 Million CAD | 89.71% |
| 2023 Q2 | 6.41 Million CAD | -1.93% |
| 2023 Q4 | 7.67 Million CAD | -36.91% |
| 2023 FY | 7.67 Million CAD | 17.21% |
| 2023 Q1 | 6.53 Million CAD | -0.15% |
| 2022 Q4 | 6.54 Million CAD | 1466.75% |
| 2022 Q1 | 467 Thousand CAD | -4.69% |
| 2022 Q2 | 443 Thousand CAD | -5.14% |
| 2022 Q3 | 418 Thousand CAD | -5.64% |
| 2022 FY | 6.54 Million CAD | 1236.53% |
| 2021 Q4 | 490 Thousand CAD | -4.48% |
| 2021 Q1 | 559 Thousand CAD | -3.95% |
| 2021 Q2 | 536 Thousand CAD | -4.11% |
| 2021 Q3 | 513 Thousand CAD | -4.29% |
| 2021 FY | 490 Thousand CAD | -15.81% |
| 2020 Q2 | 626 Thousand CAD | -3.1% |
| 2020 Q3 | 605 Thousand CAD | -3.35% |
| 2020 FY | 582 Thousand CAD | -12.74% |
| 2020 Q1 | 646 Thousand CAD | -3.15% |
| 2020 Q4 | 582 Thousand CAD | -3.8% |
| 2019 Q1 | 725 Thousand CAD | 0.0% |
| 2019 Q3 | 687 Thousand CAD | -2.83% |
| 2019 Q4 | 667 Thousand CAD | -2.91% |
| 2019 FY | 667 Thousand CAD | 0.0% |
| 2019 Q2 | 707 Thousand CAD | -2.48% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | -100.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | -100.0% |
| 2008 Q3 | 2.13 Million CAD | 1.96% |
| 2008 Q4 | 2.17 Million CAD | 1.92% |
| 2008 FY | 2.17 Million CAD | 8.17% |
| 2008 Q2 | 2.09 Million CAD | 2.0% |
| 2008 Q1 | 2.04 Million CAD | 2.04% |
| 2007 Q2 | 1.92 Million CAD | 2.18% |
| 2007 Q4 | 2 Million CAD | 2.14% |
| 2007 Q1 | 1.88 Million CAD | 0.0% |
| 2007 FY | 2 Million CAD | 8.95% |
| 2007 Q3 | 1.96 Million CAD | 2.08% |
| 2006 FY | 1.84 Million CAD | -76.19% |
| 2006 Q3 | 1.87 Million CAD | 2.01% |
| 2006 Q2 | 1.84 Million CAD | -80.83% |
| 2006 Q1 | 9.59 Million CAD | 2.5% |
| 2005 FY | 7.74 Million CAD | 15.53% |
| 2005 Q4 | 9.36 Million CAD | 6.12% |
| 2005 Q1 | 7.74 Million CAD | 7.5% |
| 2005 Q2 | 8.28 Million CAD | 6.97% |
| 2005 Q3 | 8.82 Million CAD | 6.52% |
| 2004 Q3 | 6.9 Million CAD | -1.61% |
| 2004 Q2 | 7.01 Million CAD | 4.69% |
| 2004 Q4 | 7.2 Million CAD | 4.35% |
| 2004 FY | 6.7 Million CAD | 12.34% |
| 2004 Q1 | 6.7 Million CAD | 5.16% |
| 2003 Q1 | 5.96 Million CAD | 9.27% |
| 2003 FY | 5.96 Million CAD | 11.5% |
| 2003 Q4 | 6.37 Million CAD | 1636.24% |
| 2003 Q3 | 367 Thousand CAD | -93.34% |
| 2003 Q2 | 5.5 Million CAD | -7.68% |
| 2002 Q4 | 5.45 Million CAD | -19.61% |
| 2002 Q2 | 5.15 Million CAD | -3.59% |
| 2002 Q1 | 5.35 Million CAD | 0.83% |
| 2002 FY | 5.35 Million CAD | 61.73% |
| 2002 Q3 | 6.79 Million CAD | 31.66% |
| 2001 Q2 | 4.96 Million CAD | 50.03% |
| 2001 Q1 | 3.3 Million CAD | 6.16% |
| 2001 Q3 | 5.21 Million CAD | 5.0% |
| 2001 Q4 | 5.3 Million CAD | 1.82% |
| 2001 FY | 3.3 Million CAD | 10.27% |
| 2000 Q3 | 3.1 Million CAD | 3.53% |
| 2000 FY | 3 Million CAD | 150.0% |
| 2000 Q2 | 3 Million CAD | 0.0% |
| 2000 Q4 | 3.11 Million CAD | 0.32% |
| 2000 Q1 | 3 Million CAD | 50.0% |
| 1999 Q1 | 1.2 Million CAD | -33.33% |
| 1999 Q4 | 2 Million CAD | 25.0% |
| 1999 FY | 1.2 Million CAD | 1100.0% |
| 1999 Q3 | 1.6 Million CAD | 45.45% |
| 1999 Q2 | 1.1 Million CAD | -8.33% |
| 1998 Q3 | 1.8 Million CAD | 1700.0% |
| 1998 Q2 | 100 Thousand CAD | 0.0% |
| 1998 FY | 100 Thousand CAD | -75.0% |
| 1998 Q4 | 1.8 Million CAD | 0.0% |
| 1998 Q1 | 100 Thousand CAD | 0.0% |
| 1997 Q3 | 200 Thousand CAD | -33.33% |
| 1997 Q4 | 100 Thousand CAD | -50.0% |
| 1997 Q1 | 400 Thousand CAD | 0.0% |
| 1997 FY | 400 Thousand CAD | -20.0% |
| 1997 Q2 | 300 Thousand CAD | -25.0% |
| 1996 Q2 | 500 Thousand CAD | 0.0% |
| 1996 Q3 | 400 Thousand CAD | -20.0% |
| 1996 FY | 500 Thousand CAD | 400.0% |
| 1996 Q1 | 500 Thousand CAD | 25.0% |
| 1996 Q4 | 400 Thousand CAD | 0.0% |
| 1995 Q2 | 100 Thousand CAD | 0.0% |
| 1995 Q4 | 400 Thousand CAD | 300.0% |
| 1995 FY | 100 Thousand CAD | 0.0% |
| 1995 Q1 | 100 Thousand CAD | 0.0% |
| 1995 Q3 | 100 Thousand CAD | 0.0% |
| 1994 Q2 | 100 Thousand CAD | 0.0% |
| 1994 Q1 | 100 Thousand CAD | 0.0% |
| 1994 FY | 100 Thousand CAD | 0.0% |
| 1994 Q4 | - CAD | -100.0% |
| 1994 Q3 | 100 Thousand CAD | 0.0% |
| 1993 FY | 100 Thousand CAD | 0.0% |
| 1993 Q1 | 100 Thousand CAD | -21.7% |
| 1992 Q4 | 127.7 Thousand CAD | 2.34% |
| 1992 Q2 | 119.61 Thousand CAD | 0.0% |
| 1992 Q3 | 124.78 Thousand CAD | 4.32% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -127833.333% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -491.593% |
| Biocept, Inc. | 10.37 Million USD | 26.014% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 85.039% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 87.463% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -1305.027% |
| iMD Companies, Inc. | 1.1 Million USD | -595.5% |
| IDenta Corp. | 428.17 Thousand USD | -1692.721% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -80.91% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -2661.151% |
| NovelStem International Corp. | 3.32 Million USD | -130.885% |
| Optigenex Inc. | 4.42 Million USD | -73.388% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -370.632% |
| Response Genetics, Inc | 4.91 Million USD | -56.08% |
| Rennova Health, Inc. | 359.19 Thousand USD | -2037.013% |
| RushNet, Inc. | 4.25 Million USD | -80.51% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -2982.112% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -861.373% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -1231.756% |
| Todos Medical Ltd. | 33 Million USD | 76.74% |